Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention

OBJECTIVES: Trimetazidine is an anti-ischemic medication licensed for the treatment of angina pectoris. However, the molecular mechanisms underlying its action remain incompletely elucidated. In this study, therefore, we examined the potential beneficial effects of trimetazidine on myocardial injury...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiol Res Pract
Main Authors: Shao, Shuai, Shi, Zhaozhao, Tse, Gary, Wang, Xinghua, Ni, Yanping, Liu, Hongmei, Liu, Tong, Li, Guangping
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745110/
https://ncbi.nlm.nih.gov/pubmed/31565429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4230948
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados